Glycyrrhizin in licorice root neutralizes SARS-CoV-2 in vitro by inhibiting the main protease Mpro

NewsGuard 100/100 Score

COVID-19 disease, caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes a range of symptoms from mild to severe respiratory illness. Unfortunately, even pre-symptomatic patients or those with very mild symptoms are infectious and can infect other people.

The need of the hour is effective and well-tolerated therapeutic options to treat patients with severe COVID-19. Besides compounds such as remdesivir have been approved or authorized for emergency use to treat COVID‑19, traditional herbal medicines are considered promising candidates for the complementary treatment of viral diseases and recently suggested for the treatment of COVID-19.

Analyzing the neutralizing activity of licorice root extract against SARS-CoV-2 in vitro

In a recent bioRxiv* preprint paper, researchers from Germany analyzed aqueous licorice root extract for its neutralizing activity against SARS-CoV-2 in vitro. They identified glycyrrhizin, the primary active ingredient in the root, and revealed the underlying mechanism of viral neutralization.

The licorice roots were dried and brewed, and the resulting fluid was sterile filtered to obtain an aqueous extract of the root. The neutralization capacity of the extract was determined in cell culture using endpoint dilution. Cytotoxicity was determined at 4 time points - 5 minutes, 12 hours, 24 hours and 4 hours - using the “Orangu cell counting solution”, which is an assay that uses NAD(P)H concentration and dehydrogenase enzyme activity to detect cell vitality.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Licorice root extract neutralized SARS-CoV-2 even at a subtoxic concentration

The licorice root extract exhibited neutralizing effects even at a subtoxic concentration of 2 mg/ml, which is lower than the typical consuming dilution. For example, in tea, it is 12.5 mg/ml. Although this shows that licorice root tea may be a candidate for complementary use as an antiviral, it is crucial that the active compound is identified and characterized for its potential consideration in clinical applications.

“Complete virus neutralization was achieved at subtoxic concentrations of 0.5 mg/ml under pre- and  1 mg/ml under post-entry conditions.”

Glycyrrhizic acid - antiviral active ingredient in licorice root

Glycyrrhizic acid is a triterpene saponin that is found in high concentrations in the root of the Glycyrrhiza glabra plant. It was found to be the active antiviral ingredient in licorice root and it exhibits antiviral activity against many viruses, including herpes simplex viruses, the human immunodeficiency virus (HIV), and human and animal coronaviruses.

An in-silico simulation study suggested antiviral activity of glycyrrhizin against SARS-CoV-2, but this hypothesis had not been experimentally proved. Based on the results obtained in the aqueous licorice root extract, the researchers investigated the neutralizing activity of glycyrrhizic acid against a SARS-CoV-2 isolate and subsequently examined the mechanism of neutralization.

“Glycyrrhizin was clinically evaluated in the context of a clinical trial and described to be a safe and well-tolerated compound”

Glycyrrhizin inhibits SARS-CoV-2 main protease

The human transmembrane serine protease (TMPRSS2) has been shown to cleave the SARS-CoV-2 spike protein S, thus facilitating the entry of the virus into the host cell. However, the researchers found only a tiny difference in the antiviral activity of glycyrrhizin between pre- and post-entry conditions. So they concluded that glycyrrhizin neutralizes the virus by a mechanism that is different from inhibition of TMPRSS2 and hence focused on the SARS-CoV-2 main protease (Mpro) as its potential target.

“Taken together, we demonstrated that glycyrrhizin, the primary active ingredient of the licorice root, potently neutralizes SARS-CoV-2 by inhibiting the viral main protease.”

Mpro is responsible for the processing of viral polyproteins translated from the viral RNA and hence essential for virus replication. In their experiments, researchers found that glycyrrhizin fully inhibited Mpro activity at a concentration of 2000 µM (1.6 mg/ml) and reduced Mpro activity by 70.3% at a concentration of 30 µM (0.024 mg/ml). Thus, they concluded that glycyrrhizin effectively neutralizes SARS-CoV-2 by inhibiting the viral main protease Mpro. These findings highlight glycyrrhizin as a promising antiviral compound that should be further studied for use in the treatment of COVID-19.

“The potent antiviral activity as well as anti-inflammatory properties highlight glycyrrhizin as an excellent candidate for further clinical investigations in COVID-19 treatment.”

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • Apr 4 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Susha Cheriyedath

Written by

Susha Cheriyedath

Susha is a scientific communication professional holding a Master's degree in Biochemistry, with expertise in Microbiology, Physiology, Biotechnology, and Nutrition. After a two-year tenure as a lecturer from 2000 to 2002, where she mentored undergraduates studying Biochemistry, she transitioned into editorial roles within scientific publishing. She has accumulated nearly two decades of experience in medical communication, assuming diverse roles in research, writing, editing, and editorial management.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cheriyedath, Susha. (2023, April 04). Glycyrrhizin in licorice root neutralizes SARS-CoV-2 in vitro by inhibiting the main protease Mpro. News-Medical. Retrieved on May 23, 2024 from https://www.news-medical.net/news/20210105/Glycyrrhizin-in-licorice-root-neutralizes-SARS-CoV-2-in-vitro-by-inhibiting-the-main-protease-Mpro.aspx.

  • MLA

    Cheriyedath, Susha. "Glycyrrhizin in licorice root neutralizes SARS-CoV-2 in vitro by inhibiting the main protease Mpro". News-Medical. 23 May 2024. <https://www.news-medical.net/news/20210105/Glycyrrhizin-in-licorice-root-neutralizes-SARS-CoV-2-in-vitro-by-inhibiting-the-main-protease-Mpro.aspx>.

  • Chicago

    Cheriyedath, Susha. "Glycyrrhizin in licorice root neutralizes SARS-CoV-2 in vitro by inhibiting the main protease Mpro". News-Medical. https://www.news-medical.net/news/20210105/Glycyrrhizin-in-licorice-root-neutralizes-SARS-CoV-2-in-vitro-by-inhibiting-the-main-protease-Mpro.aspx. (accessed May 23, 2024).

  • Harvard

    Cheriyedath, Susha. 2023. Glycyrrhizin in licorice root neutralizes SARS-CoV-2 in vitro by inhibiting the main protease Mpro. News-Medical, viewed 23 May 2024, https://www.news-medical.net/news/20210105/Glycyrrhizin-in-licorice-root-neutralizes-SARS-CoV-2-in-vitro-by-inhibiting-the-main-protease-Mpro.aspx.

Comments

  1. Alberto González Alberto González North Macedonia says:

    Also Liquiritin (another component of Licorice root) was confirmed early on to have anti-viral activity against SARS-CoV-2:

    https://doi.org/10.1101/2020.05.02.074021

  2. Pawan Joshi Pawan Joshi India says:

    as mentioned in the article - "These findings highlight glycyrrhizin as a promising antiviral compound that should be further studied for use in the treatment of COVID-19" - is there any further study till data and can you please update the outcome for the benefit of the current situation of pandemic.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study sheds light on the biological properties of new COVID variant Pirola